The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. METHODS: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. RESULTS: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. CONCLUSION: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800 · cited 14×
“Metabolic risk factors We compared and pooled RRs for the effects of key metabolic risk factors: SBP, TC, FPG, and adiposity measured by BMI, from major global pooling projects.”
BackgroundInfluentialCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Research works printed but not linked: 2
- James WPT, Jackson-Leach R, Ni Mhurchu C, Kalamara E, Shayeghi M, <etal>et al</etal>.. (2004) Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
- Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, <etal>et al</etal>.. (2004) High Blood Pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
Cited by
Items 601–700 of 772
Anoma, O. Q., Hall, W. L., Villemonteix, J., Canfell, O. J., & Duncan, A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102110 · Cited by 1
Wilson, C. L., Dhaduk, R., Zhou, X., Matt, G. Y., Yasui, Y., Im, C., Armstrong, G. T., Dixon, S. B., Sapkota, Y., Wang, Z., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf356 · Cited by 1
Chiu, C.-Y., Tzeng, C., Liu, S.-W., Chen, C., Yu-Hsiang, K., Hu, C., & Chen, W. (2026) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/adpp/8627692 · Cited by 1
Pérez-Miguel, E., & Trias‐Llimós, S. (2026) · SSM - Population Health · doi:10.1016/j.ssmph.2026.101904 · Cited by 1
“CVD risk factors have an important effect on CVD outcomes (Singh et al., 2013): 21% of deaths from ischaemic heart disease and 13% of stroke worldwide (30 + years) were attributable to higher-than-optimum blood glucose (diabetes) (Danaei et al., 2006); obesity was associated with a 63% higher risk…”
Health care professionals’ postpartum nutritional counselling to women; a mixed-methods approach
Faessen, J. P. M., Mattijssen, S., van Lonkhuijzen, R. M., Feskens, E. J. M., Wagemakers, A., & Brouwer-Brolsma, E. M. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14211-z · Cited by 1
“A healthy diet is known to support this resilience and adaptation by beneficially influencing a woman’s breast-milk supply, nutrient status [1–3], body weight [4, 5] and on the long-term even the risk of cardiovascular disease, some cancers, diabetes, and arthritis [6–10].”
Ren, X., Guo, Y., Li, B., Xu, T., Wang, B., Yang, L., Han, J. Z., Zhou, Y., & Zhou, B. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c15793 · Cited by 1
Global dietary estimates for conducting health, environmental and economic impact assessments
Springmann, M. (2026) · Nature Food · doi:10.1038/s43016-026-01388-z · Cited by 1
Towhidi, F., Salamat, K. M., Soroush, A., & Pourmotabbed, A. (2020) · Journal of Clinical Research in Paramedical Sciences · doi:10.5812/jcrps.100716 · Cited by 1
“Obesity increases the risk of numerous diseases such as diabetes (2), cardiovascular diseases (1, 2), different cancers (3), and musculoskeletal disorders (4), all of which have negative effects on the quality of life, efficiency, and healthcare costs.”
BackgroundApetite emocional em situações negativas e padrão alimentar de mulheres adultas
Paiva, Y. L. M., Cacau, L. T., Sampaio, H. A. D. C., Adriano, L. S., Carioca, A. A. F., Arruda, S. P. M., & Sabry, S. D. (2021) · Revista Brasileira em Promoção da saúde · doi:10.5020/18061230.2021.10829 · Cited by 3
Prediction of 10-Year Risk of Cardiovascular Disease among Diabetic Patients in Bangladesh
Akter, N. (2022) · Delta Medical College Journal · doi:10.3329/dmcj.v8i1.58961 · Cited by 1
Actual Benefits of Zinc for Cardiovascular Diseases: Mini Review
Jebur, N. J., & Yahya, R. N. (2022) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v3i.92 · Cited by 1
Obesity is a Major Health Problem Threatening the Iraqis- review article
(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.05.053 · Cited by 3
Ghosal, S., & Sinha, B. (2022) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_8_23 · Cited by 1
AlGethami, A. K., Altowairqi, R. M., Alqthami, A., Altowairqi, R. M., Alamri, K., Algethami, L. M., & Alotaibi, F. K. (2024) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2024.95257621 · Cited by 1
Agarwal, T., Lyngdoh, T., Khadgawat, R., Dudbridge, F., Kinra, S., Relton, C. L., Smith, G. D., Ebrahim, S. B. J., Prabhakaran, D., Chandak, G. R., et al. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01570-y · Cited by 1
Singh, J., Tripathi, V. S., Kant, R., & Lal, J. A. (2024) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921317994240906051408 · Cited by 1
Chillo, P., Muhihi, A. J., Danaei, G., Bakari, M., Kwesigabo, G., Njelekela, M. A., Ulenga, N. K., Fawzi, W. W., Mugusi, F. M., & Sudfeld, C. R. (2024) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/23259582241281010 · Cited by 1
Self-citationObesity as a medical and social problem
Амлаев, К. Р., Atoeva, M., & Жарылкасынова, Г. Ж. (2024) · Vrach · doi:10.29296/25877305-2024-11-06 · Cited by 1
Ahmed, W., Dixit, P., & Halli, S. S. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1386378 · Cited by 6
Jaromin, J., Markiewicz‐Łoskot, G., Szydłowski, L., Kulawik, A., Chlebowczyk, A., & Moric‐Janiszewska, E. (2024) · Archives of Medical Science · doi:10.5114/aoms/176675 · Cited by 1
“Abnormal weight in early life predisposes not only to ischemic heart disease, but also to arrhythmias [5, 6].”
Dietary behaviour among adults in Northern Ghana: a polytomous logistic regression model approach
Opare‐Asamoah, K., Kpewou, D. E., Sosu, J. X., Degbey, V. E., Vicar, E. K., Dongdem, J. T., Majeed, S. F., & Antwi, K. F. (2025) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2025.2467850 · Cited by 1
“28 These increasing conditions pose a huge toll on the individual, household, community, national, and global economies through increasing instances of DALYs.”
Kim, E., Hong, S.-E., Choi, Y. S., Yu, S., Kang, J., Park, C. G., Lee, H. Y., Lee, S. K., Lee, D. C., Hwang, W. M., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s510541 · Cited by 3
Who knows what ‘healthy weight’ looks like?
Flanagan, R., Waugh, D., Meng, X., Kanjo, E., & Krejany, C. (2018) · The Journal of Health Design · doi:10.21853/jhd.2018.49 · Cited by 1
“Excess body weight is a well-known risk factor associated with numerous chronic diseases and some malignancies.(2,3)”
BackgroundZeng, H., Luo, M., Li, Z., Wen, J., He, G., Jin, Y., Fu, W., & Zhou, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029426 · Cited by 2
Wanjari, S. K., Ghogale, P. R., Singh, D., & Mendhe, H. G. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20195649 · Cited by 1
Koziolova, N. A., Karavaev, P. G., & Veklich, A. S. (2020) · Kardiologiia · doi:10.18087/cardio.2020.4.n1042 · Cited by 1
Comparison and Analysis of Epidemiologic Characteristics of Stroke in Sichuan Province, China
Liu, Q., Xu, X., Fang, J., Deng, Y., & He, L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00877 · Cited by 1
Discriminative stimulus effects of an imidazolidine-derived appetite suppressant
Young, R. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-02853-7 · Cited by 1
Extracellular RNAs from immune cells under obesity—a narrative review
Karlinsey, K. S., Matz, A., Qu, L., & Zhou, B. (2022) · ExRNA · doi:10.21037/exrna-22-15 · Cited by 1
Latent growth analysis of children’s height growth trajectories
Wake, S. K., Zewotir, T. T., & Muluneh, E. K. (2022) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174422000617 · Cited by 2
Arpegård, J. (2015) · Figshare · Cited by 1
Iniciativas para a redução do consumo de sódio no Brasil: avaliação e análise de impacto
Nilson, E. A. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2020.tde-19012021-135250 · Cited by 2
Sex and Gender Differences in Cardiovascular Disease
Mathews, L. M., Chandrashekar, P., Prasad, M., Miller, V. M., Sharma, K., Sedlak, T., Merz, C. N. B., & Ouyang, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.64153-4 · Cited by 1
Fogelholm, M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734229568.793555246 · Cited by 1
Special Issue: “Genes and Human Diseases”
Churnosov, M. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084455 · Cited by 1
Trang, B. K., Pahl, M. C., Pippin, J. A., Su, C., Littleton, S. H., Sharma, P. K., Kulkarni, N. N., Ghanem, L. R., Terry, N. A., O’Brien, J. M., et al. (2024) · eLife · doi:10.7554/elife.95411.1.sa0 · Cited by 1
Trang, B. K., Pahl, M. C., Pippin, J. A., Su, C., Littleton, S. H., Sharma, P. K., Kulkarni, N. N., Ghanem, L. R., Terry, N. A., O’Brien, J. M., et al. (2024) · eLife · doi:10.7554/elife.95411.1 · Cited by 1
Chen, X., Zhou, S., Zhang, Y., Zhong, Q., Sun, F., Xu, R. J., Sun, Z., Sun, J., Yang, L., Yan, S., et al. (2025) · medRxiv · doi:10.1101/2025.05.15.25327656 · Cited by 1
Diabetes: La Epidemia Actual, Intervenciones y posibles estrategias de Prevención.
Espinoza‐Morales, F. (2014)
Lu, Y. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Yuzvenko, Т. Y., & Pankiv, V. (2016) · EUREKA Health Sciences · doi:10.21303/2504-5679.2016.00099
“But it is well-known, that metabolic disorders favor the disturbances in immune system, especially, in patients with DM type 2 takes place the metabolic immune suppression [2, 3].”
Fyysisen aktiivisuuden, masennusoireiden ja tyypin 2 diabeteksen välinen yhteys
Helminen, A. (2016) · Jyväskylä University Digital Archive (University of Jyväskylä)
OBSOLETE: Sex and Gender Differences in Cardiovascular Disease
Ouyang, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64153-3
Rebello, C. J. (2015) · Louisiana State University · doi:10.31390/gradschool_dissertations.1469
Impacto na saúde humana de disruptores endócrinos
Pontelli, R. C. N. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-06012017-110954 · Cited by 1
Zheng, Y., Fang, D. H., Wang, M., Ma, X., Xu, M., & He, S. (2017) · Journal of Obesity and Weight-loss Medication · doi:10.23937/2572-4010.1510019
Respiratory Pathologies Associated with Obesity
Alvarado, A. (2018) · Clinical Research and Trials · doi:10.15761/crt.1000236
“BMI has become a risk factor for a group of chronic diseases in expansion that include cardiovascular, metabolic, musculoskeletal, neoplastic, psychological, renal, gallbladder and respiratory disorders [3-5].”
BackgroundMlambo, S. S. (2018) · UpSpace Institutional Repository (University of Pretoria)
Matos, W. L., Klinger, E. I., Rodrigues, S. T., Reuter, C. P., Todendi, P. F., & Valim, A. R. D. M. (2018) · Revista Jovens Pesquisadores · doi:10.17058/rjp.v8i2.11921
Albattarni, G. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.43.2019.tde-30012019-131637
Sazonova, O. V., Myakisheva, Y. V., Михайловна, Б. Л., Gavryushin, M. Y., & Gorbachev, D. O. (2018) · Экология человека · doi:10.33396/1728-0869-2018-4-59-64
Prevention of diabetes through lifestyle intervention: effects on liver fat and brain
Drummen, M. (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190124md · Cited by 1
Relationship between self-rated health status and physical activity in obese South Indian patients
Joena, V., & Ananda Xavier Pragasam, R. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20192238
Zhuravlyova, L., & Filonenko, M. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.2.2019.166106
Marklund, M., Singh, G. M., Greer, R. C., Cudhea, F., Matsushita, K., Micha, R., Brady, T. M., Zhao, D., Huang, L., Tian, M., et al. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz051.or25-05-19
Self-citationPeng, Y. (2019) · The University of Queensland · doi:10.14264/uql.2019.539
Pharmacoepigenetics in Type 2 Diabetes Mellitus
DiStefano, J. K., & Watanabe, R. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00018-8
Evaluation of the New Onset Diabetes Education Program for Navajo Adults.
Bartley, D. (2018) · ProQuest LLC eBooks
de Araújo, I. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-12062019-135753
Chumairoh, S. (2018) · ARKAVI [Arsip Kardiovaskular Indonesia) · doi:10.22236/arkavi.v3i1.3688
Metabolic changes after bariatric surgical procedures
Ahmed, M., Hummady, S., & ALgazgoos, F. (2020) · Iraqi National Journal of Medicine · doi:10.37319/iqnjm.2.1.2
Obesidad y síndrome metabólico (excluyendo diabetes e hipertensión) en donante y receptor
Arreola-Guerra, J. M. (2020) · Revista Mexicana de Trasplantes · doi:10.35366/93495
Sazonova, O. V., Myakisheva, Y. V., Михайловна, Б. Л., Гинзбург, M. М., Gavryushin, M. Y., Gorbachev, D. O., & Frolova, O. (2018) · Science and Innovations in Medicine · doi:10.35693/2500-1388-2018-0-3-21-24
The Obesity Paradox Existing in Idiopathic Pulmonary Arterial Hypertension
Şentürk, B., Akdeniz, B., Özpelit, E., Yılmaz, M. B., Kahraman, B. Ö., Sezgin, D., Tertemiz, K. C., & Sevinç, C. (2020) · e-Journal of Cardiovascular Medicine · doi:10.32596/ejcm.galenos.2020.02.011
“Obesity is associated with several health problems, including the increased risk of cardiovascular and respiratory diseases (3-5) .”
Саволюк, С. І., Lysenko, V. M., Кrestіanov, М. Y., Zavertylenko, D. S., & Kruhliak, Y. (2020) · Medicni perspektivi · doi:10.26641/2307-0404.2020.1.200412
Role of NLRP3 Inflammasomes in Obesity-Induced Cardiovascular Diseases
Boini, K. M., Li, P., & Koka, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_5
Gharib, A. F., Ismail, K. A., Arab, M., Etewa, R. L., & Raafat, N. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100817
Horta-Gim, M. A. (2021) · Buleria (Universidad de León) · doi:10.18002/10612/12938
Thisted, L., Østergaard, M. V., Pedersen, A. A., Pedersen, P. J., Lindsay, R. T., Murray, A. J., Fink, L. N., Pedersen, T. X., Secher, T., Johansen, T. T., et al. (2020) · doi:10.21203/rs.3.rs-19735/v1
Cystatin C in Patients with Coronary Artery Disease
Mohamed, M. W. (2020) · Clinical Cardiology and Cardiovascular Interventions · doi:10.31579/2641-0419/047
“Traditional risk factors lose some of their predictive ability with increasing age (4) and their predictive ability in established disease is not as well studied in healthy cohorts.”
BackgroundPanbehkar‐Jouybari, M., Mollahosseini, M., Panjeshahin, A., & Hosseinzadeh, M. (2021) · Nutrition & Food Science · doi:10.1108/nfs-05-2021-0160 · Cited by 2
Ghosal, S., & Sinha, B. (2022) · Research Square · doi:10.21203/rs.3.rs-1569242/v1
IMPACTO DO CORONAVÍRUS EM PACIENTES CARDIOPATAS: UMA REVISÃO INTEGRATIVA
Silva, R. L., Cariolano, D. D. S., Leite, M. J. F. L., Murad, L. M. D. A., Marinho, L. C. O., Miranda, B. G., Maia, A. V. F. B., Filho, M. S. C., Guterres, L. V. A., Chagas, E. L. C., et al. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-8
DIFICULDADES DE ADESÃO AO TRATAMENTO DA HANSENÍASE NO MARANHÃO: UMA REVISÃO DE LITERATURA
Reis, A. C. C., Lima, A. B. D. C. M., Souza, A. L. D. S. E., Sousa, A. C. C. M., Correia, A. D. A. C., de Oliveira, E. T. C., Guimarães, E. R., Neto, F. F. C., de Lima, G. V., de Sousa, G. P., et al. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-7
ASSISTÊNCIA ATUAL NO SUS AO PACIENTE COM DIABETES
Alves, A. P. D., Costa, A. V. B. D. S., Mousinho, E. B., Neto, J. D. C. G., Lemos, J. R., do Rosário, L. C. V., Curvina, B. L. S., Leal, D. A. P., Salgado, D. R. G. B., & de Melo, S. M. B. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-1
ANSIEDADE EM GESTANTES ATENDIDAS NA ATENÇÃO BÁSICA
Machado, L. M., Machado, M. L. M., Cipriano, A. M. V., de Alencar, A. C. S., Fernandes, I. M. B., Aires, A. K. C., Coan, F. F., Cruz, J. G., da Silva, A. A. C., & Assunção, I. L. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-9
AS DERMATOZOONOSES MAIS PREVALENTES NO BRASIL E SUA SITUAÇÃO NA SAÚDE PÚBLICA DO PAÍS
Santos, A. M. R., Gomes, D. R. D. A., Marques, L. M. R., Brandão, M. L. B., Gomes, M. D. J. C., Silva, R. C. D. L. L. E., Costa, R. R. M., Pereira, S. G. P. J., & Torres, M. A. O. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-3
OBESIDADE COMO FATOR DE AGRAVAMENTO EM PACIENTES ACOMETIDOS POR COVID-19: UMA REVISÃO DE LITERATURA
Castro, K. D. S. K., Costa, G. A. D. A., Moreira, I. M. M., Machado, L. M., Sampaio, M. K. D. L., Pereira, P. C. L., & Torres, M. A. O. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-2
Sousa, J. C. D. S., Assunção, I. L., Castro, K. D. S. K., & Neto, V. F. (2022) · Luminus editora eBooks · doi:10.29327/558996
Aires, A. K. C., Rabelo, A. C. M. C., Carneiro, M. E. D. C. P., Pavão, F. M. F. A., da Silva, R. M., Pereira, Y. F., Chaves, C. G., Serpa, P. G. S., Marinho, L. B., Grijó, R. M. C., et al. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-4
SARAMPO: UMA NOVA TAXA DE INCIDÊNCIA NO BRASIL
Sampaio, M. K. D. L., do Vale, M. F. A., Barroso, C. M., Castro, K. D. S. K., Sandes, M. D. A., Sousa, D. V. L. D. P., da Cruz, M. C. P. N., Ribeiro, L. M., & Torres, M. A. O. (2022) · Luminus editora eBooks · doi:10.29327/558996.2-5
Faculty Opinions recommendation of Repositioning of the Global Epicentre of Non-Optimal Cholesterol.
Fazio, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738066204.793575448
Introduction: The obesity pandemic
Mehrzad, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90965-5.00015-5 · Cited by 1
Obesity and 2030 Agenda in Latin America: Prevention and Control Policies in Brazil and Chile
Motta, M. D. D. S., & Ribeiro, H. (2022) · Implementing the UN sustainable development goals - regional perspectives · doi:10.1007/978-3-030-91188-1_34-1
Overall, abdominal, and visceral obesity in men and women: an introduction
de Mutsert, R., & Després, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822186-0.00017-1
COMPARISON OF DIFFERENT ESTIMATION FUNCTIONS FOR GLOBAL HEALTH ASSESSMENT CAUSED BY AMBIENT PM2.5
SEKIZAWA, S., Watanabe, R., Fujimori, S., Oshiro, K., & Ueda, K. (2022) · Journal of Japan Society of Civil Engineers Ser G (Environmental Research) · doi:10.2208/jscejer.78.5_i_239
Clinical Potential of Glucagon-like Peptide-1 Analogs in the Management of Diabesity
Sharma, N., & Singh, S. (2023) · Journal of Diabetology · doi:10.4103/jod.jod_102_22
Aricatt, D. P., Das, R., Subramanyam, K., Ashraf, S. M., & Janakiraman, E. (2023) · European Journal of Anatomy · doi:10.52083/sano2959
Overnutrition and COVID Prevalence in India: Evidence and Implications
Dang, A., & Gupta, I. (2023) · Indian Journal of Human Development · doi:10.1177/09737030231174300
“Many of these health conditions are associated with or caused by excess body weight/fat (Pi-Sunyer, 2009; Singh et al., 2013).”
BackgroundGay, J. G., & Prada, D. (2020) · Latin American Journal of Clinical Sciences and Medical Technology · doi:10.34141/ljcs3500717 · Cited by 2
Hasibuan, S. R., Sabarinah, S., & Darmawan, E. S. (2023) · Jurnal Ekonomi Kesehatan Indonesia · doi:10.7454/eki.v8i1.6829 · Cited by 2
BMI and DM: a two-sample mendelian randomization studyPreprint
Yuan, J., Jiang, Q., & Yu, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3232845/v1
Robertson, J., Muszta, A., Lindgren, M., af Geijerstam, A., Nyberg, J., Lissner, L., Börjesson, M., Gisslén, M., Rosengren, A., Adiels, M., et al. (2023) · Obesity Science & Practice · doi:10.1002/osp4.709 · Cited by 1
Metadata
- Authors
- Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., Di Angelantonio, E., vander Hoorn, S., Lawes, C. M. M., Ali, M. K., Mozaffarian, D., Ezzati, M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC), (DECODE), D. E. C. A. O. D. C. I. E., Emerging Risk Factor Collaboration (ERFC), & Prospective Studies Collaboration (PSC)
- Affiliations
- Harvard University (US)
- Tehran University of Medical Sciences (IR)
- World Health Organization (CH)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- University of Helsinki (FI)
- University of Auckland (NZ)
- Emory University (US)
- Brigham and Women's Hospital (US)
- MRC Centre for Environment and Health (GB)
- Corresponding author
- Ezzati, Majid
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-30
- Volume
- 8
- Issue
- 7
- Pages
- e65174
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3728292
- OpenAlex
- W2122520859
- Cited by
- 772
- References
- 67
- Citations by year
- 2026: 29 · 2025: 64 · 2024: 84 · 2023: 87 · 2022: 103 · 2021: 86 · 2020: 85 · 2019: 66 · 2018: 43 · 2017: 49 · 2016: 41 · 2015: 18 · 2014: 16 · 2013: 1
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/013/25942, RG/07/008/23674, RG/08/014/24067)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Medical Research Council (MR/K005901/1, MR/L003120/1)
- Economic and Social Research Council (ES/F02679X/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK007703., T32DK007703)
- National Institute of Environmental Health Sciences (P30ES005605)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic risk factors, cardiovascular disease, diabetes mellitus, systolic blood pressure, total cholesterol, fasting blood glucose, body mass index, ischemic heart disease, hypertensive heart disease, stroke, sex differences, pooled cohort analysis, relative risk, effect modification by age
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk, Sex Factors, Body Mass Index, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.